Zymeworks (ZYME) Gains from Investment Securities (2021 - 2024)

Zymeworks has reported Gains from Investment Securities for 4 years, with the latest figure at -$1.2 million in Q2 2024.

• Quarterly Gains from Investment Securities changed N/A year-over-year to -$1.2 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was -$1.2 million (down 107.03% YoY) and the FY2024 annual result came in at -$1.9 million, down 398.1% from the prior year.
• Gains from Investment Securities declined to -$1.2 million in Q2 2024 per ZYME's latest filing, from -$700000.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $499000.0 in Q1 2023 and troughed at -$1.2 million in Q2 2024.
• A 4-year average of -$188000.0 and a median of -$168000.0 in 2023 frame the typical range for Gains from Investment Securities.
• The widest YoY moves for Gains from Investment Securities: up 240.28% in 2024, down 240.28% in 2024.
• Over 4 years, Gains from Investment Securities stood at $182000.0 in 2021, then slumped by 237.36% to -$250000.0 in 2022, then soared by 219.6% to $299000.0 in 2023, then tumbled by 493.98% to -$1.2 million in 2024.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$1.2 million, -$700000.0, and $299000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.